Analysis of the TCGA dataset showed a wide range of IDO-1 expression among different cancer types, with the highest median expression in diffuse large B-cell lymphoma and the lowest median expression in acute myeloid leukemia (Figure 1A). This evidence concerns the gene IDO1 and diffuse large B-cell lymphoma.